The individual response to NAC appears to be mostly dependent on the tumor molecular profile [24]: tumors lacking hormone receptors are more sensitive to cytotoxic chemotherapy [25], and, within triple-negative tumors, those overexpressing EGFR are the most responsive [26]. Here, EGFR is linked to neoplasm.